Skip to main content
Top
Published in: Supportive Care in Cancer 4/2024

Open Access 01-04-2024 | Radiotherapy | Research

Effectiveness of Comprehensive Intervention Programme on Quality of life, fatigue, self-efficacy, and psychosocial distress among head and neck cancer patients receiving radiotherapy

Authors: Shalini Ganesh Nayak, Anice George, Krishna Sharan, Baby S. Nayak, N. Ravishankar

Published in: Supportive Care in Cancer | Issue 4/2024

Login to get access

Abstract

Purpose

The study aimed at evaluating the Effectiveness of Comprehensive Intervention Programme (CIP) on Quality of life (QOL), fatigue, self-efficacy, and psychosocial distress among Head and Neck Cancer (HNC) patients receiving radiotherapy treatment.

Methods

Single-centre non-RCT time series study was conducted among 134 HNC patients (67 observed, followed by 67 subjected to CIP). FACT- H&N, FACT-F, Cancer Behavior Inventory and psychosocial distress scales were used to assess QOL, fatigue, self-efficacy, and psychosocial distress respectively. CIP was provided to the intervention arm twice a week during the course of radiation therapy along with the standard care; the control arm received only standard care. Data were collected before commencing radiotherapy, and post-test assessments were carried out at the end of radiotherapy treatment, and at 3 and 6 months after completion of radiotherapy.

Results

Repeated measures ANOVA revealed a statistically significant improvement with CIP in QOL (F (1.917) = 454.103, p = 0.001), fatigue (F (2.106) = 183.775, p = 0.001), self-efficacy (F (2.429) = 190.861, p = 0.001), and psychosocial distress (F (2.288) = 290.105, p = 0.001) in the intervention arm.

Conclusion

The CIP implemented to address multitude of issues in HNC patients receiving radiotherapy, proved to be effective in reducing the impact of treatment on QOL, fatigue, self-efficacy and psychosocial distress in HNC patients receiving radiotherapy.
Literature
20.
go back to reference Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655CrossRefPubMed Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655CrossRefPubMed
23.
go back to reference Heitzmann CA, Merluzzi TV, Jean-Pierre P et al (2011) Psycho-Oncology - 2011 - Heitzmann - assessing self-efficacy for coping with cancer development and psychometric analysis.pdf. Psychooncology 20:302–312CrossRefPubMed Heitzmann CA, Merluzzi TV, Jean-Pierre P et al (2011) Psycho-Oncology - 2011 - Heitzmann - assessing self-efficacy for coping with cancer development and psychometric analysis.pdf. Psychooncology 20:302–312CrossRefPubMed
28.
go back to reference Burgos-Mansilla B, Galiano-Castillo N, Lozano-Lozano M et al (2021) Effect of physical therapy modalities on quality of life of head and neck cancer survivors: a systematic review with meta-analysis. J Clin Med 10:. https://doi.org/10.3390/jcm10204696 Burgos-Mansilla B, Galiano-Castillo N, Lozano-Lozano M et al (2021) Effect of physical therapy modalities on quality of life of head and neck cancer survivors: a systematic review with meta-analysis. J Clin Med 10:. https://​doi.​org/​10.​3390/​jcm10204696
Metadata
Title
Effectiveness of Comprehensive Intervention Programme on Quality of life, fatigue, self-efficacy, and psychosocial distress among head and neck cancer patients receiving radiotherapy
Authors
Shalini Ganesh Nayak
Anice George
Krishna Sharan
Baby S. Nayak
N. Ravishankar
Publication date
01-04-2024
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2024
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-024-08381-x

Other articles of this Issue 4/2024

Supportive Care in Cancer 4/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine